Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2023-10-26 Board/Management Inform…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
第四届董事会第二十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 20th meeting of the 4th Board of Directors of Yunnan Shengwu Gu Pharmaceutical Co., Ltd. It details the meeting's attendance, agenda items, voting results, and references to other announcements for detailed content. The document does not contain financial statements or detailed financial data but rather reports on board decisions and governance matters such as amendments to company bylaws and meeting notices. It is not a full report like an annual or quarterly report, nor is it a call transcript or earnings release. The content fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management. The document length is under 5,000 characters and is a direct announcement of board meeting resolutions, not a report publication announcement or regulatory filing. Therefore, the classification is MANG with high confidence.
2023-10-26 Chinese
董事会制度
Governance Information Classification · 95% confidence The document is titled '云南生物谷药业股份有限公司 董事会制度' which translates to 'Yunnan Bio Valley Pharmaceutical Co., Ltd. Board of Directors System'. It details the rules, composition, powers, meeting procedures, and responsibilities of the company's board of directors. There is no financial data, earnings information, or report publication mentioned. The content is focused on governance structure and internal board rules. This matches the description of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices. The document length is substantial (9796 characters), indicating it is the actual governance document, not just an announcement. Therefore, the correct classification is CGR with high confidence.
2023-10-26 Chinese
募集资金管理制度
Governance Information Classification · 95% confidence The document is titled '云南生物谷药业股份有限公司 募集资金管理制度' which translates to 'Yunnan Biovalley Pharmaceutical Co., Ltd. Fundraising Capital Management System'. It details the company's internal policies and procedures regarding the management, storage, use, supervision, and changes related to raised funds. The document includes references to board meetings, shareholder meetings, regulatory compliance, and internal controls over fundraising capital. It is a detailed policy document rather than a financial report, earnings release, or announcement of voting results. It does not contain financial statements or earnings data, nor is it a brief announcement or a presentation. It is a governance-related document outlining internal rules and procedures for managing raised capital. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7441 characters) supports it being a full policy document rather than a short announcement.
2023-10-26 Chinese
关于控股股东、实际控制人收到中国证券监督管理委员会云南监管局行政监管措施决定书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding an administrative regulatory measure decision issued by the China Securities Regulatory Commission (CSRC) Yunnan Bureau. It details the regulatory action taken against the controlling shareholder and actual controller for failing to fulfill a stock increase commitment. The document includes the regulatory decision, the nature of the violation, the impact on the company, and the company's response measures. It does not contain financial statements, audit results, or detailed financial performance data. It is not a full annual or interim report, nor is it a certification or a simple announcement of a report. The content fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about compliance and administrative measures without substantive financial data or report content.
2023-09-20 Chinese
关于控股股东、实际控制人收到中国证券监督管理委员会云南监管局行政监管措施决定书的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from a company regarding an administrative regulatory measure decision issued by the China Securities Regulatory Commission (CSRC) Yunnan Bureau. It details the regulatory action taken against the controlling shareholder and actual controller for failing to fulfill a stock increase commitment. The document includes the regulatory decision, the nature of the violation, the impact on the company, and the company's response measures. It is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about a compliance issue and administrative sanction. The document length is about 2047 characters, relatively short, and it serves as a formal regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-09-20 Chinese
股票解除限售公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the lifting of stock trading restrictions (解除限售公告) for certain shares of the company. It details the number of shares becoming tradable, the shareholders involved, reasons for lifting restrictions, and the updated share capital structure. There is no financial performance data, no discussion of earnings, no management commentary, and no regulatory certification. The document is a formal notification about changes in share trading status, specifically the removal of lock-up restrictions on shares. This fits the category of Share Issue/Capital Change (SHA), as it relates to changes in the capital structure and share tradability rather than a financial report or other corporate filing type.
2023-09-18 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.